{{Rsnum
|rsid=7480010
|Gene=LOC387761
|Chromosome=11
|position=42225168
|Orientation=plus
|GMAF=0.4045
|Gene_s=LOC100505897,LOC100507205
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 54.0 | 36.3 | 9.7
| HCB | 62.8 | 32.1 | 5.1
| JPT | 64.6 | 29.2 | 6.2
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 38.6 | 61.4
| CHB | 62.8 | 32.1 | 5.1
| CHD | 57.8 | 38.5 | 3.7
| GIH | 33.7 | 54.5 | 11.9
| LWK | 0.0 | 2.7 | 97.3
| MEX | 67.2 | 25.9 | 6.9
| MKK | 0.0 | 14.1 | 85.9
| TSI | 45.1 | 34.3 | 20.6
| HapMapRevision=28
}}

rs7480010 increases susceptibility to Type II Diabetes 1.14 times for heterozygotes (AG) and 1.40 times for homozygotes (GG) {{PMID|17293876}}

{{PMID Auto
|PMID=21153532
|Title=Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men
}}
{{PMID Auto
|PMID=21198374
|Title=LOC387761 Polymorphism Is Associated with Type 2 Diabetes in the Mexican Population
}}

{{PMID Auto
|PMID=21510814
|Title=Association of Genetic Variations in TCF7L2, SLC30A8, HHEX, LOC387761, and EXT2 with Type 2 Diabetes Mellitus in Tunisia
}}

{{PMID Auto
|PMID=17786204
|Title=Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
|OA=1
}}

{{PMID Auto
|PMID=18162508
|Title=Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.
}}

{{PMID Auto
|PMID=18443202
|Title=Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies.
|OA=1
}}

{{PMID Auto
|PMID=18461161
|Title=Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.
|OA=1
}}

{{PMID Auto
|PMID=18544707
|Title=Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
|OA=1
}}

{{PMID Auto
|PMID=18556337
|Title=Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).
|OA=1
}}

{{PMID Auto
|PMID=18633108
|Title=Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.
|OA=1
}}

{{PMID Auto
|PMID=18654633
|Title=Simultaneous analysis of all SNPs in genome-wide and re-sequencing association studies.
|OA=1
}}

{{PMID Auto
|PMID=18689899
|Title=Exchangeable models of complex inherited diseases.
|OA=1
}}

{{PMID Auto
|PMID=19008344
|Title=Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians.
|OA=1
}}

{{PMID Auto
|PMID=19502414
|Title=Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men.
|OA=1
}}

{{PMID Auto
|PMID=21278902
|Title=Genetic risk profiling for prediction of type 2 diabetes.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}